A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

NCT00528372 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1067

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: Dapagliflozin placebo
DRUG: Metformin

Sponsor

AstraZeneca

Collaborators

[object Object]